Absorption of lawsone through human skin

Cutaneous and Ocular Toxicology

Volumn 26, Issue 1, 2007, Pages 45-56

  Kraeling, Margaret E K ^a   Bronaugh, Robert L ^a   Jung, Connie T ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Human skin; Lawsone; Percutaneous absorption

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; BUFFER; CARBON 14; HAIR DYE; HENNA; LAWSONE; SHAMPOO;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERMATOME; DIFFUSION; HUMAN; HUMAN TISSUE; REACTION TIME; SKIN ABSORPTION; TISSUE LEVEL;

CARBON RADIOISOTOPES; DIFFUSION CHAMBERS, CULTURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HAIR DYES; HUMANS; NAPHTHOQUINONES; POWDERS; REPRODUCIBILITY OF RESULTS; SKIN; SKIN ABSORPTION; SOAPS; SOLUTIONS; TIME FACTORS;

LAWSONIA INERMIS;

EID: 34247581780     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520601183856     Document Type: Article

References (18)

1. Kirkland D, Marzin D. An assessment of the genotoxicity of 2-hydroxy-1,4-naphthoquinone, the natural dye ingredient in henna. Mut Res 2003; 537:183-199.
2. Nohynek GJ, Fautz R, Benech-Kieffer F, Toutain H. Toxicity and human health risk of hair dyes. Food Chem Tox 2004; 42:517-543.
3. U.S. Code of Federal Regulations, 1982, Title 21, Section 73.2190.
4. The Scientific Committee for Cosmetics and Non-Food Products (SCCNFP): Opinion of the SCCNFP concerning Lawsone. 2002.
5. The Scientific Committee on Consumer Products (SCCP): Opinion of the SCCP on Lawsonia inermis (Henna). 2005.
6. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. J Pharm Sci 1985; 74:64-67.
7. Kraeling MEK, Bronaugh RL. In vitro percutaneous absorption of alpha hydroxy acids in human skin. J Soc Cos Chem 1997; 48:187-197.
8. Collier SW, Sheikh NM, Sakr A, Lichtin JL, Stewart RF, Bronaugh RL. Maintenance of skin viability during in vitro percutaneous absorption=metabolism studies. Toxicol Appl Pharmacol 1989; 99:522-533.
9. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies VI: Preparation of the barrier layer. J Pharm Sci 1986; 75:487-491.
10. Bronaugh RL, Stewart RF, Simon M. Methods for in vitro percutaneous absorption studies VII: Use of excised human skin. J Pharm Sci 1986; 75:1094-1097.
11. Yourick JJ, Bronaugh RL. Percutaneous penetration and metabolism of 2-nitro-p-phenylenediamine in human and fuzzy rat skin. Tox App Pharm 2000; 166:13-23.
12. European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Technical Report No. 58. Assessment of Nonoccupational Exposure to Chemicals, 1994:20-21.
13. Cosmetic, Toiletry and Fragrance Association (CTFA). 1983. Summary of the results of surveys of the amount and frequency of use of cosmetic products by women. Prepared by Environ Corporation, Washington, DC for CTFA., Washington, DC. 1-7.
14. Hood HL, Wickett RR, Bronaugh RL. The in vitro percutaneous absorption of the fragrance ingredient musk xylol. Fd Chem Tox 1996; 34:483-488.
15. Kraeling MEK, Yourick JJ, Bronaugh RL. In vitro human skin penetration of diethanolamine. Fd Chem Tox 2004; 42:1553-1561.
16. Yourick JJ, Koenig ML, Yourick DL, Bronaugh RL. Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption? Tox Appl Pharm 2004; 195:309-320.
17. Anonymous, OECD Guideline for the Testing of Chemicals: Skin Absorption (in vitro method), Organization for Economic Cooperation and Development, Paris, 2004; 1-8.
18. Anonymous. Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients, updated 2003, Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers, European Commission, 2003; 1-9.